To validate the relationships between FAM171B expression and survival rates in bladder cancer, we utilized an integrated cohort of 613 patients from datasets in the GEO database (GSE13507/GSE31684/GSE32894/GSE37815). Here, FAM171B is linked to urinary bladder carcinoma.